185 related articles for article (PubMed ID: 34217847)
1. Thrombotic Microangiopathy Increases the Risk of Chronic Kidney Disease but Not Overall Mortality in Long-term Transplant Survivors.
Li A; Gupta R; Amos CI; Davis C; Pao E; Lee SJ; Hingorani SR
Transplant Cell Ther; 2021 Oct; 27(10):864.e1-864.e5. PubMed ID: 34217847
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience.
Sartain S; Shubert S; Wu MF; Srivaths P; Teruya J; Krance R; Martinez C
Biol Blood Marrow Transplant; 2019 Jan; 25(1):157-162. PubMed ID: 30144562
[TBL] [Abstract][Full Text] [Related]
3. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
[TBL] [Abstract][Full Text] [Related]
5. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.
Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S
Transplant Cell Ther; 2023 Mar; 29(3):151-163. PubMed ID: 36442770
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
Schoettler M; Lehmann L; Li A; Ma C; Duncan C
Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
[TBL] [Abstract][Full Text] [Related]
7. Late Kidney Morbidity and Mortality in Hematopoietic Cell Transplant Survivors.
Wu NL; Hingorani S; Cushing-Haugen KL; Lee SJ; Chow EJ
Transplant Cell Ther; 2021 May; 27(5):434.e1-434.e6. PubMed ID: 33775588
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort.
Schoettler M; Lehmann LE; Margossian S; Lee M; Kean LS; Kao PC; Ma C; Duncan CN
Blood Adv; 2020 Jun; 4(11):2536-2547. PubMed ID: 32516415
[TBL] [Abstract][Full Text] [Related]
9. Changes in Glomerular Filtration Rate and Impact on Long-Term Survival among Adults after Hematopoietic Cell Transplantation: A Prospective Cohort Study.
Hingorani S; Pao E; Stevenson P; Schoch G; Laskin BL; Gooley T; McDonald GB
Clin J Am Soc Nephrol; 2018 Jun; 13(6):866-873. PubMed ID: 29669818
[TBL] [Abstract][Full Text] [Related]
10. Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy.
Epperla N; Li A; Logan B; Fretham C; Chhabra S; Aljurf M; Chee L; Copelan E; Freytes CO; Hematti P; Lazarus HM; Litzow M; Nishihori T; Olsson RF; Prestidge T; Saber W; Wirk B; Yared JA; Loren A; Pasquini M
Br J Haematol; 2020 Jun; 189(6):1171-1181. PubMed ID: 32124435
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and outcomes of pediatric transplant-associated thrombotic microangiopathy in Hong Kong.
Chan WYK; Ma ALT; Chan EYH; Kan ANC; Ng WF; Lee PPW; Cheuk DKL; Chiang AKS; Leung W; Chan GCF
Pediatr Transplant; 2022 Nov; 26(7):e14366. PubMed ID: 35860972
[TBL] [Abstract][Full Text] [Related]
12. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
[TBL] [Abstract][Full Text] [Related]
13. Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation.
Glezerman IG; Jhaveri KD; Watson TH; Edwards AM; Papadopoulos EB; Young JW; Flombaum CD; Jakubowski AA
Biol Blood Marrow Transplant; 2010 Jul; 16(7):976-84. PubMed ID: 20153836
[TBL] [Abstract][Full Text] [Related]
14. Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal.
Li A; Wu Q; Davis C; Kirtane KS; Pham PD; Sorror ML; Lee SJ; Gopal AK; Dong JF; Garcia DA; Weiss NS; R Hingorani S
Biol Blood Marrow Transplant; 2019 Mar; 25(3):570-576. PubMed ID: 30940363
[TBL] [Abstract][Full Text] [Related]
15. Chronic Kidney Disease in Long-Term Survivors after Allogeneic Hematopoietic Stem Cell Transplantation: Retrospective Analysis at a Single Institute.
Jo T; Arai Y; Kondo T; Kitano T; Hishizawa M; Yamashita K; Takaori-Kondo A
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2159-2165. PubMed ID: 28822830
[TBL] [Abstract][Full Text] [Related]
16. Renal Complications after Hematopoietic Stem Cell Transplantation: Role of Graft-Versus-Host Disease in Renal Thrombotic Microangiopathy.
Mii A; Shimizu A; Yamaguchi H; Tsuruoka S
J Nippon Med Sch; 2020 Mar; 87(1):7-12. PubMed ID: 31776318
[TBL] [Abstract][Full Text] [Related]
17. Severe transplant-associated thrombotic microangiopathy in patients with hemoglobinopathies.
Abusin GA; Abu-Arja R; Bajwa RPS; Horwitz EM; Auletta JJ; Rangarajan HG
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28333416
[TBL] [Abstract][Full Text] [Related]
18. Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis.
Gutiérrez-García G; Villarreal J; Garrote M; Rovira M; Blasco M; Suárez-Lledó M; Rodríguez-Lobato LG; Charry P; Rosiñol L; Marín P; Pedraza A; Solano MT; Ramos C; de Llobet N; Lozano M; Cid J; Martínez C; Poch E; Carreras E; Urbano-Ispizua Á; Fernández-Avilés F; Pereira A; Quintana LF
Bone Marrow Transplant; 2020 Jul; 55(7):1264-1271. PubMed ID: 32103146
[TBL] [Abstract][Full Text] [Related]
19. Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation.
Postalcioglu M; Kim HT; Obut F; Yilmam OA; Yang J; Byun BC; Kupiec-Weglinski S; Soiffer R; Ritz J; Antin JH; Alyea E; Koreth J; Cutler C; Armand P; Paik JM; Leaf DE; Ho VT; Abdi R
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2344-2353. PubMed ID: 29758394
[TBL] [Abstract][Full Text] [Related]
20. Chronic kidney disease in long-term survivors of hematopoietic cell transplant.
Hingorani S; Guthrie KA; Schoch G; Weiss NS; McDonald GB
Bone Marrow Transplant; 2007 Feb; 39(4):223-9. PubMed ID: 17290279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
